pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-561 |
Genomic Coordinates | chr2: 188297492 - 188297588 |
Synonyms | MIRN561, hsa-mir-561, MIR561 |
Description | Homo sapiens miR-561 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-561-3p | |||||||||||||||||||||||||||||||||||||||||||||||||
Sequence | 61| CAAAGUUUAAGAUCCUUGAAGU |82 | |||||||||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||||||||||||||||||
Experiments | SAGE | |||||||||||||||||||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
DRVs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CHIC1 | ||||||||||||||||||||
Synonyms | BRX | ||||||||||||||||||||
Description | cysteine rich hydrophobic domain 1 | ||||||||||||||||||||
Transcript | NM_001039840 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CHIC1 | |||||||||||||||||||||
3'UTR of CHIC1 (miRNA target sites are highlighted) |
>CHIC1|NM_001039840|3'UTR 1 GGAGTTTTATCCAGTCACTTCTGTGTTACCTGTCATTTCCTACCCTTAGTGCCTTGTAGATTTGGAATGAAGATGGTCTC 81 CTTTGCTGTGTTCAACTTATTCTTTATAATGGTAGAATATTCTTCTCGCTCTTTTGTGTTGGTTTATGAAGAAAATTTGC 161 ACATCTTTTTTGTCTTTCAATGAGGCTTGTGTTTTGCACTCTCAATTTTAAATACACACACATGCGTGTGTGCATATACA 241 TATATAGATAGTTGCCATTAAAGATAAATCATCAGTGTTGGTGTTTAAAAAACAAAAACTTGTTCTGAGCATGCTGCCTT 321 ATAATTTTCATACTCATTGTTTCTAAACTCGCATCATTTTTCTAGGCTACTTGATGCTCTGTAATCCCTTACTGGACAAA 401 CTTAAATAAGCTTTTGGTAGCTTTTAGAAATGGTTTTACTCTGCTTTTAAAGGACATGCTTTTAAAGGACATGCAATTAA 481 TGGCACTGGTTTTGTCCTGCACTTTGCTTTATCACTTATGTTAGTGGATAAAATATTTAAACTCCTAAAGACTTGTAAAT 561 ATTGCCTCTTTGCATAATGTAAAATGTGGTATGCCATGGTTTACATAATGTAACATTACTCTTATTGTATTGCCAACAAT 641 TTTACATAGATTTTAATATGAATGAAGTTTGCAAGCATCCCTTTGAATGTAGAAACTGCTAACATGCTGTTTTATGGCAA 721 GGCCATAATGAGTATGTTAAGAATTTCAGGTGTAGGGCAAGGTTGCCCTTTGTAACAAGTGGACTAAAATTGAAATTATT 801 ATCTCAGATATTCTGTATTGCACCTGAAACCATGACCTTTATTTTTCCATTTCGTTTAATAATTTCCATTTTGTTGTCTA 881 CTCCTTCCCACAAAAAAACTATTTGACATCTGACACATTTCACAGTCTCACTATCCTGCATTTATTAGCCTTTTCTTCCT 961 TTGAAAATACACACAATTATGACTTTTAAGGAGTATTTTGAGATTTCAGACATCTTCAGAAGGTATCTAGACCCTCTTGA 1041 AAGCCACTAACACCTTTCTGCAGTTCTGATATTCTAGTTTGAGAAAGAGAGAGAACTATTTGAGAAGCTGTAGCTAAAGA 1121 GTATATAGCAGCTGATTCATAATTGAAAAAAAATTCTCAATTCTGTTTTTGATGATCCTTTATAAAACATTAATGAGGAA 1201 AGACAAGTGTTTAGACAAAAGTATTTTAGTTTATAAATTCAGCACATATGTAACATTTATTTGGTCCATATTTCTCTATT 1281 TTTCTTCACAATTAAAATGATTGCTAGCACCACACAACTAGAATTTGAAAATTCAGTATAATGAAAGCTTTATATCACAT 1361 TAATTCAACTGCAAATGTATGCCTGTTTGTAGGCATTATTTGTAATTCATAGTGCTAAAAATAAAAGTGTCTAGGGCTCA 1441 GTAATATTTTGTCATCTTACTCTTACTGCTTTTAGTAAACCTTTTAGGCAAGATTCATCTCAGTGAAGTGAACAATCATT 1521 TCTTCATAGAAGGTCAAGCCTTTTTAAGCCACTCTTAAAATTTATGCCTAATTTGAAATCCACAGTCCTTGACCAGTTTA 1601 AAAAAGAGAGGAAAAAGAAGACACTATTTTATATGTGATTATAATTGTTTGCACAAACACTTTTCCACCTTCCTCTGTGC 1681 CCCATTACCTCTGTGCCACTCAGTCACCCCAAATCTCTAACCTTTAGTAATGTGTATGCCTGCAAATATTATGTGTTTGC 1761 CTGCTGCAAAATTGAAGGTGTATTTTTATAGACAAGGTAGAAGCCTCTGAAAATGTATACCAAATGTCTTGTTTTGTAGC 1841 TAAGGTCGGGAAAAATTGTATCTGAGGTTTATGTTCCAGCTAATGTTATCAAATTTATGCTTCAAACTGTGATATTTTAA 1921 TACCAAAATCGATTTTCAGCATAATACAAAATATCTCATTTTCACTGATAGAAAATTGCTTTTAAGTGTTGATCCTTAGA 2001 AATCTTATTTTTTTCTATAACCTTAGAATTTGATCATATGATGGTCATAGGAACTTTTTCTGCCATGTATAAATCACACT 2081 TGGTTTTGCTCAAAGAACAGCATGAAGTGGTGAATTGTTTCCATGAAACAATTATTGAGAATGGGAATACAGTATATCTG 2161 GAAATGACACAGTATAATACAAGTTACAGTAGCATTTGTCACAAAAACCACTTGTCAGCATGTGTAAACTTAATTTTAAA 2241 GCCTATTCTAATCACTCGAGTTTATTATTTTATTGTTCGCTATGCTGGTTGACTCATCTTAGTTTCTTCAACTACCCAAA 2321 AAAATACCAATTTTTTTCCTCTCTTGTATGACTACTTTTTCAAACTGTTTTCCTTTGCAGGGGGCTGATTAGCAATTGAG 2401 TATTTTGTAATGTTTGGGCGGGGTTGCTTTGTTTTCAGTGAAATTGGTTGCAGTGAATGCTAAAATGACACAGCACACTG 2481 GTGATTAATTCCTCCCCCATGGAGCCTTTTTTCTGTTATGCTTAGGATAGAACATACTTGTAATTTTCCATTAGGTTAGT 2561 AACATACTTTTGTGAAAGTTGTTTTTAGACTGAAGAAAGTAATTTTGAATTTCTTTGTTACATAATATTCCTTTATGAAA 2641 CTTGTGATAGTTTCCAGAGCAAAACATGTATTTGCCAAAGTATATAAATCTCACAAGGCTTTAAGATTACAAGCTAAAAT 2721 TGTTTTTTAAAATTAATGTTCCAATGTTTCTCATTTGGCCCAAGATTCTGGCTTCATAAATTTGTCCAACTGGCTATTTT 2801 TAAGCTTGTCCTAAAAGCCAATAACATGTTTATTCCTAATAACTAATATGGGCAAGTGTTATTTACAGATTTATTAACTC 2881 CATCCCAGATATGTCTCCACTCTTTGTTCCCTCCTAATGCTAATTTAGGAAAGAGACCACTGTAGTAAAACTTTAGAAGA 2961 AGATGGAGAAGTGCCTTGTCTTTTTAGAACAAAGATAACACATTACGTGTAAGGAAGCATAATAAATGAATTGGTAGATG 3041 ATTAGATTAGAAATCATCCTTTTCAACTAGGTCTAAGAATACTTTACTAGTGTATTATCTTTTATTTATTATGTAAAGCT 3121 TCTTTCCTTCCTTTTCCCCAATCATGATATATTAGTGACAAAATATTACAGAACCGGACTATCAGTCACTTAAAAAAACA 3201 GTATAATTCTAATGCTAGTAAACATGTAATTTAATTTAGTTCTGGAAGGACAGTTGTCTTTGATTAAAGCCCCACCAAAA 3281 CCCATTTAAGTATTTAATGTACATACTATTCATATTATTATGGCCTGTAAACACTAATATCTGAGCAATCAAACTGTTTT 3361 ATCTACCATTTTTGATGAAATTTGAATAAAGTTTAAAAACGTGTAAGCCTTTGAACAAATGTATGAAAGCTTTAAAAGAT 3441 CATTAGCACTTTTATTTTGTTTACAAATAAGCTGCCATTTAAAAAAATAAAACCTCACTACTTGAACATAAAGCTCCCAA 3521 ACAATATTGTATTAAAATGTACTATATTGACCTAGGAGGATATAGAAATTATATTCACCTGATTAACTGGAGCAGTTTCA 3601 CATAGTAGAAATACTTTTTGCTAATTTGATTATAAGTGCTCAAATTTATTGAAATTAGATTCTCATGCCTATAAAAGTAT 3681 ACTTTAAAAATATTTTGCAACAACTGTCAAATTATTTGGGTTCCTTTAAATAGCAAACAATTGGGAAATTTTCCATAAAA 3761 ATGAATAGGTTTTATTAATACCTGTTCATGTAGTATGTGGACTAAAACAATTGATATATATCTGTATGTAAAAATGAATG 3841 ATCTTATCTTGCCCCAAATTTTTCTTACCTGATTCTGAGCCAGCCTTTTTGTTTTGATGGCACCCTGTGAGTATGTTCCA 3921 TTTTCTGTGAACTTTGTCAAATTCATACTATATGAGGAAATGATCTAATATTGTGGGCTCCAGGCAGGTCATCTTAATTG 4001 CATGTCTGTCTCTTCTGTAAAATGATGAGGTGGAACCTAGAGCTGGACAAAAAATTAGAGATCACTTAACATTCTGTGAT 4081 TCAAGGAATTCTTAGGACATTTTTACTCTATAGAATCTCAGAATGATTATTCTCAGATCTACTGTCCTTGGTGGAAACTC 4161 TCACAGTGCCTTGCATGCAGTAAAAGTTTGATTTGCCGACTGGCTGACGTGTTAATTATCACACAGACTCCAAGAACCTG 4241 ATGCTTGCTAGACCTTAGTTCCTTGGTGATGCTAAGAGTAAATGTAGTTTTCCTAGGAACTGAGCACTGAGGTCTGTGTC 4321 CTTTGCCTGTGTAGAATCTGTCTATGCAGTTGGTATTCAGGCAAGAATTTTAGCTGTAACAACAATGGAAATATTGGAGG 4401 ACCCACTTTGGCATTTATGTAAAGATTTCATATCCTATCCAACATTTACTTTAGTGTCTAATCAAATTCCATACCCTCAA 4481 AAAGATCTGTTGGAACAAATTGATAAAATTAGGTGGAAAGGAAAGTGGTATGGGACTCAAATACAAGTCACTTCTGGTTT 4561 AATTATTGGCTCTGCTGCTTAATTCCTCTGTACCTCACGTCCTCATTGTCGAAGTGGGGACAATAATCTGGACCTACCTC 4641 ACAGGGGAATTGAGGATATTTTCATATATTAGTGTGCTTTGAAGTTGACTGAAAGATATACTGGATATCATAATTATATA 4721 ATTTCTAAATAGATTTCTTTAAATCCATGCTATGTTTTCTTTTTCAGTCAGGTCCTACAGAATGACTATTGCACTTGGTC 4801 TATTGTTTTAATAGTAAATTTTGTTATTAATCTCCTATGTGTTAAACGTGGGTAATTGTATTATGTTAATACATACTTAG 4881 GGAGGAAAAGCAGGTGGATGTAAATCAGTGATTCCCAACTTCAGCAGATGATAGCAGTGGAGGGTATCCTTGAGCTTTTT 4961 GTAATATTTCAAAAAGTATATTAGAAATTATACATTTACCCATAATATTCCTGCTTCACAAGTCAATTAAGACATTGAAT 5041 TTCCATTCATTTTGCCTATATTCTCTCAAAAGCTGTGAATGGCAGTATGTTTTTGATTAATAATAAAATAAGAAATCCTA 5121 TTATGTGCAACTTATTAAATACTTGGGAACATGGGAAAAGAATAATGAAGGGATTCTTATGGTGAAAATGTTGGGAACCA 5201 CTTTTATAAAGGAACTAAGATTATTTGACCCCCTCCACAGATTGCTTACCTAGTCTCTAAATAATGAAATGTGTGTGTTT 5281 GTGTGTTTTGGCTATATTAGGCTATATAACTTCAGGTTAGAATTTGCCTTCAGTTTTTTTTCTGTTTTAGAATATCACTG 5361 GCCTAATTTATTTAGGTGTGTACATGTTGCTCATACATACACACACATATAGGATTACAAATGTGGAAAATGTTATAATG 5441 TCATATTCTAGCATTGGACTAAATATCAATTTCTGACTCTTAAAGTAGTTCTGTGTATAAATTCAACATGATGAATCAAG 5521 GCAATAATTTCTCAAATGTTCTTTTATTTCTTTGTTTTTATCTCGACTTTTTATTTTCCATTTTTTCTAGTACGCAAATA 5601 GTGTAAAATTGTTTTAATGCCTGGACTTTGAAACAAGTAACAAGTGTTTGAAAGTATATAATCTACGAGCGAATTTGCCC 5681 TCCTTGGACTAACCACATACAAATATGAATCTGGCTGCAAGAACAGGATATCCAGGTAACTAGAGAGTGGGCATTGATAA 5761 AAATATCTGGTGGAGAAGCCTAGGATTTCAACTTTTTGTCAGAGGATTCCTGTTGGGACAGCTTTACCAGAAAAGAATAA 5841 TAGCGGATATGTTCATCCAAACTAAGAACTTTCATGCATCTTGCATTGTTACATAGCCTGTGGAATGAATTCATTTTTTC 5921 TCCCTTGAGTCCAGGAATGACTTCCCTGGAAAAACTCAATCTATATACAGCTGTGCCAAAATGAAGGATACCTGCCTCTC 6001 CGAAACTTTCACTGCTGCTTCTGTCATTGTTCACTTGTCAGATAAAATTTTATTATCTCAGGATGCAAATTTAAAATAAA 6081 GTGTAAATCTATGTTAATGAATTG Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545212. RNA binding protein: AGO1. Condition:Control
PAR-CLIP data was present in GSM545214. RNA binding protein: AGO3. Condition:Control
PAR-CLIP data was present in GSM545215. RNA binding protein: AGO4. Condition:Control
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
PAR-CLIP data was present in GSM545217. RNA binding protein: AGO2. Condition:miR-7 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 53344.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 53344.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065667. RNA binding protein: AGO1. Condition:4-thiouridine
"PAR-CLIP data was present in GSM1065668. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
CLIP-seq Support 1 for dataset GSM545212 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000373504.6 | 3UTR | CUUUCACUGCUGCUUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM545214 | |
---|---|
Method / RBP | PAR-CLIP / AGO3 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000373504.6 | 3UTR | AACUUUCACUGCUGCUUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM545215 | |
---|---|
Method / RBP | PAR-CLIP / AGO4 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000373504.6 | 3UTR | ACUUUCACUGCUGCUUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000373504.6 | 3UTR | AAACUUUCACUGCUGCUUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM545217 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-7 transfection |
Location of target site | ENST00000373504.6 | 3UTR | ACUUUCACUGCUGCUUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000373504.6 | 3UTR | AAACUUUCACUGCUGCUUCUGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000373504.6 | 3UTR | AAACUUUCACUGCUGCUUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM1065667 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_6 |
Location of target site | ENST00000373504.6 | 3UTR | AAACUUUCACUGCUGCUUCUGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM1065668 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_7 |
Location of target site | ENST00000373504.6 | 3UTR | CUUUCACUGCUGCUUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
133 hsa-miR-561-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT072097 | CHAC1 | ChaC glutathione specific gamma-glutamylcyclotransferase 1 | 2 | 4 | ||||||||
MIRT080799 | SH3GLB1 | SH3 domain containing GRB2 like, endophilin B1 | 2 | 4 | ||||||||
MIRT088833 | MSH6 | mutS homolog 6 | 2 | 2 | ||||||||
MIRT093446 | MSMO1 | methylsterol monooxygenase 1 | 2 | 2 | ||||||||
MIRT099908 | SOX4 | SRY-box 4 | 2 | 10 | ||||||||
MIRT107568 | VLDLR | very low density lipoprotein receptor | 2 | 2 | ||||||||
MIRT130135 | TXNIP | thioredoxin interacting protein | 2 | 2 | ||||||||
MIRT136944 | FNDC3A | fibronectin type III domain containing 3A | 2 | 2 | ||||||||
MIRT158447 | TNRC6B | trinucleotide repeat containing 6B | 2 | 2 | ||||||||
MIRT161901 | FXR1 | FMR1 autosomal homolog 1 | 2 | 2 | ||||||||
MIRT166271 | C5ORF51 | chromosome 5 open reading frame 51 | 2 | 4 | ||||||||
MIRT187291 | CLIC4 | chloride intracellular channel 4 | 2 | 4 | ||||||||
MIRT202308 | CEBPB | CCAAT/enhancer binding protein beta | 2 | 2 | ||||||||
MIRT210742 | PPP4R2 | protein phosphatase 4 regulatory subunit 2 | 2 | 2 | ||||||||
MIRT249020 | PABPC3 | poly(A) binding protein cytoplasmic 3 | 2 | 2 | ||||||||
MIRT268845 | C1ORF21 | chromosome 1 open reading frame 21 | 2 | 2 | ||||||||
MIRT304688 | GTF2E1 | general transcription factor IIE subunit 1 | 2 | 2 | ||||||||
MIRT316774 | FOXC1 | forkhead box C1 | 2 | 2 | ||||||||
MIRT325708 | CSTF2 | cleavage stimulation factor subunit 2 | 2 | 2 | ||||||||
MIRT327970 | CHIC1 | cysteine rich hydrophobic domain 1 | 2 | 6 | ||||||||
MIRT328758 | DHODH | dihydroorotate dehydrogenase (quinone) | 2 | 2 | ||||||||
MIRT356391 | RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 2 | 2 | ||||||||
MIRT437448 | NR0B1 | nuclear receptor subfamily 0 group B member 1 | 1 | 1 | ||||||||
MIRT441383 | FRS2 | fibroblast growth factor receptor substrate 2 | 2 | 2 | ||||||||
MIRT442496 | PCDH10 | protocadherin 10 | 2 | 4 | ||||||||
MIRT444054 | PROX2 | prospero homeobox 2 | 2 | 2 | ||||||||
MIRT446062 | RABIF | RAB interacting factor | 2 | 2 | ||||||||
MIRT446714 | FUT10 | fucosyltransferase 10 | 2 | 2 | ||||||||
MIRT456384 | CRB1 | crumbs 1, cell polarity complex component | 2 | 2 | ||||||||
MIRT457022 | ACADSB | acyl-CoA dehydrogenase, short/branched chain | 2 | 2 | ||||||||
MIRT457056 | NEGR1 | neuronal growth regulator 1 | 2 | 2 | ||||||||
MIRT457353 | RAD51AP1 | RAD51 associated protein 1 | 2 | 2 | ||||||||
MIRT466850 | STX6 | syntaxin 6 | 2 | 2 | ||||||||
MIRT471347 | PELO | pelota mRNA surveillance and ribosome rescue factor | 2 | 2 | ||||||||
MIRT474051 | LONRF1 | LON peptidase N-terminal domain and ring finger 1 | 2 | 2 | ||||||||
MIRT479058 | CNOT6L | CCR4-NOT transcription complex subunit 6 like | 2 | 8 | ||||||||
MIRT479398 | CDKN1B | cyclin dependent kinase inhibitor 1B | 2 | 8 | ||||||||
MIRT492072 | TMED7 | transmembrane p24 trafficking protein 7 | 2 | 2 | ||||||||
MIRT492810 | PCBP1 | poly(rC) binding protein 1 | 2 | 6 | ||||||||
MIRT494861 | ZNF99 | zinc finger protein 99 | 2 | 2 | ||||||||
MIRT496888 | TMTC2 | transmembrane and tetratricopeptide repeat containing 2 | 2 | 2 | ||||||||
MIRT498041 | TAOK1 | TAO kinase 1 | 2 | 2 | ||||||||
MIRT500856 | SYPL1 | synaptophysin like 1 | 2 | 8 | ||||||||
MIRT501323 | RNFT1 | ring finger protein, transmembrane 1 | 2 | 2 | ||||||||
MIRT502795 | CELSR3 | cadherin EGF LAG seven-pass G-type receptor 3 | 2 | 6 | ||||||||
MIRT503684 | SLC46A1 | solute carrier family 46 member 1 | 2 | 2 | ||||||||
MIRT506383 | NUFIP2 | NUFIP2, FMR1 interacting protein 2 | 2 | 2 | ||||||||
MIRT507320 | FAM60A | SIN3-HDAC complex associated factor | 2 | 6 | ||||||||
MIRT507671 | CPEB4 | cytoplasmic polyadenylation element binding protein 4 | 2 | 4 | ||||||||
MIRT510809 | SENP3 | SUMO1/sentrin/SMT3 specific peptidase 3 | 2 | 8 | ||||||||
MIRT512260 | ARPP19 | cAMP regulated phosphoprotein 19 | 2 | 6 | ||||||||
MIRT514215 | LRRC63 | leucine rich repeat containing 63 | 2 | 2 | ||||||||
MIRT517729 | NT5DC1 | 5'-nucleotidase domain containing 1 | 2 | 4 | ||||||||
MIRT520570 | TMF1 | TATA element modulatory factor 1 | 2 | 2 | ||||||||
MIRT523456 | GPBP1L1 | GC-rich promoter binding protein 1 like 1 | 2 | 6 | ||||||||
MIRT524538 | CDCA4 | cell division cycle associated 4 | 2 | 2 | ||||||||
MIRT525478 | SPIC | Spi-C transcription factor | 2 | 2 | ||||||||
MIRT532321 | GHSR | growth hormone secretagogue receptor | 2 | 2 | ||||||||
MIRT534716 | RFX7 | regulatory factor X7 | 2 | 2 | ||||||||
MIRT535042 | PRKAA1 | protein kinase AMP-activated catalytic subunit alpha 1 | 2 | 2 | ||||||||
MIRT535111 | PMEPA1 | prostate transmembrane protein, androgen induced 1 | 2 | 2 | ||||||||
MIRT536665 | INIP | INTS3 and NABP interacting protein | 2 | 2 | ||||||||
MIRT537636 | ERGIC2 | ERGIC and golgi 2 | 2 | 2 | ||||||||
MIRT537701 | ELOVL6 | ELOVL fatty acid elongase 6 | 2 | 2 | ||||||||
MIRT538060 | DMD | dystrophin | 2 | 4 | ||||||||
MIRT538811 | C21orf91 | chromosome 21 open reading frame 91 | 2 | 2 | ||||||||
MIRT539270 | ANKRD28 | ankyrin repeat domain 28 | 2 | 2 | ||||||||
MIRT541158 | PABPC1 | poly(A) binding protein cytoplasmic 1 | 2 | 2 | ||||||||
MIRT543500 | MDM2 | MDM2 proto-oncogene | 2 | 4 | ||||||||
MIRT545101 | TRIM66 | tripartite motif containing 66 | 2 | 2 | ||||||||
MIRT545328 | SLC7A5P2 | solute carrier family 7 member 5 pseudogene 2 | 2 | 2 | ||||||||
MIRT545838 | ZNF275 | zinc finger protein 275 | 2 | 2 | ||||||||
MIRT546109 | USP48 | ubiquitin specific peptidase 48 | 2 | 4 | ||||||||
MIRT548100 | GFPT1 | glutamine--fructose-6-phosphate transaminase 1 | 2 | 4 | ||||||||
MIRT549216 | BCLAF1 | BCL2 associated transcription factor 1 | 2 | 4 | ||||||||
MIRT549705 | RBM23 | RNA binding motif protein 23 | 2 | 4 | ||||||||
MIRT550139 | ZNF138 | zinc finger protein 138 | 2 | 2 | ||||||||
MIRT551104 | TTC8 | tetratricopeptide repeat domain 8 | 2 | 2 | ||||||||
MIRT551212 | MRPL35 | mitochondrial ribosomal protein L35 | 2 | 2 | ||||||||
MIRT551389 | ZNF543 | zinc finger protein 543 | 2 | 4 | ||||||||
MIRT553330 | TSC22D2 | TSC22 domain family member 2 | 2 | 2 | ||||||||
MIRT553885 | SUPT7L | SPT7 like, STAGA complex gamma subunit | 2 | 4 | ||||||||
MIRT554651 | ROBO1 | roundabout guidance receptor 1 | 2 | 2 | ||||||||
MIRT554879 | RCAN2 | regulator of calcineurin 2 | 2 | 2 | ||||||||
MIRT555602 | PIP4K2C | phosphatidylinositol-5-phosphate 4-kinase type 2 gamma | 2 | 2 | ||||||||
MIRT556467 | LMNB2 | lamin B2 | 2 | 4 | ||||||||
MIRT557838 | FNBP1L | formin binding protein 1 like | 2 | 2 | ||||||||
MIRT558143 | ENC1 | ectodermal-neural cortex 1 | 2 | 2 | ||||||||
MIRT558754 | CHERP | calcium homeostasis endoplasmic reticulum protein | 2 | 2 | ||||||||
MIRT560530 | TMEM98 | transmembrane protein 98 | 2 | 2 | ||||||||
MIRT561068 | EIF4A3 | eukaryotic translation initiation factor 4A3 | 2 | 2 | ||||||||
MIRT561384 | TWF1 | twinfilin actin binding protein 1 | 2 | 2 | ||||||||
MIRT561460 | TEAD1 | TEA domain transcription factor 1 | 2 | 2 | ||||||||
MIRT561818 | NUP155 | nucleoporin 155 | 2 | 2 | ||||||||
MIRT561963 | LSM12 | LSM12 homolog | 2 | 2 | ||||||||
MIRT562183 | HNRNPF | heterogeneous nuclear ribonucleoprotein F | 2 | 2 | ||||||||
MIRT564363 | PPWD1 | peptidylprolyl isomerase domain and WD repeat containing 1 | 2 | 2 | ||||||||
MIRT564470 | SLC35E2 | solute carrier family 35 member E2 | 2 | 2 | ||||||||
MIRT564755 | ZNF146 | zinc finger protein 146 | 2 | 2 | ||||||||
MIRT565532 | SON | SON DNA binding protein | 2 | 2 | ||||||||
MIRT565744 | SESN3 | sestrin 3 | 2 | 2 | ||||||||
MIRT566236 | PTCH1 | patched 1 | 2 | 2 | ||||||||
MIRT568636 | ACVR2A | activin A receptor type 2A | 2 | 2 | ||||||||
MIRT571081 | TCHHL1 | trichohyalin like 1 | 2 | 2 | ||||||||
MIRT571559 | YWHAQ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta | 2 | 2 | ||||||||
MIRT572246 | ANP32E | acidic nuclear phosphoprotein 32 family member E | 2 | 2 | ||||||||
MIRT572908 | RUNDC3B | RUN domain containing 3B | 2 | 2 | ||||||||
MIRT573201 | TTC19 | tetratricopeptide repeat domain 19 | 2 | 2 | ||||||||
MIRT573981 | DDX21 | DExD-box helicase 21 | 2 | 2 | ||||||||
MIRT614493 | LIX1 | limb and CNS expressed 1 | 2 | 2 | ||||||||
MIRT614579 | TMTC1 | transmembrane and tetratricopeptide repeat containing 1 | 2 | 2 | ||||||||
MIRT614898 | PAPOLG | poly(A) polymerase gamma | 2 | 2 | ||||||||
MIRT615469 | BNC2 | basonuclin 2 | 2 | 2 | ||||||||
MIRT617968 | ZNF713 | zinc finger protein 713 | 2 | 2 | ||||||||
MIRT620418 | TFDP3 | transcription factor Dp family member 3 | 2 | 2 | ||||||||
MIRT623571 | ISL1 | ISL LIM homeobox 1 | 2 | 2 | ||||||||
MIRT624902 | USP6NL | USP6 N-terminal like | 2 | 2 | ||||||||
MIRT625346 | TAPBP | TAP binding protein | 2 | 2 | ||||||||
MIRT628309 | CNN3 | calponin 3 | 2 | 2 | ||||||||
MIRT630979 | ARL4C | ADP ribosylation factor like GTPase 4C | 2 | 2 | ||||||||
MIRT637274 | KLHL12 | kelch like family member 12 | 2 | 2 | ||||||||
MIRT643959 | GALNT13 | polypeptide N-acetylgalactosaminyltransferase 13 | 2 | 2 | ||||||||
MIRT649795 | LPCAT3 | lysophosphatidylcholine acyltransferase 3 | 2 | 2 | ||||||||
MIRT653573 | SLC35B3 | solute carrier family 35 member B3 | 2 | 2 | ||||||||
MIRT653997 | SCYL3 | SCY1 like pseudokinase 3 | 2 | 2 | ||||||||
MIRT654011 | SCO1 | SCO1, cytochrome c oxidase assembly protein | 2 | 2 | ||||||||
MIRT658530 | ERP44 | endoplasmic reticulum protein 44 | 2 | 2 | ||||||||
MIRT683755 | C3orf36 | chromosome 3 open reading frame 36 | 2 | 2 | ||||||||
MIRT690907 | TOP2A | DNA topoisomerase II alpha | 2 | 2 | ||||||||
MIRT697689 | WASL | Wiskott-Aldrich syndrome like | 2 | 2 | ||||||||
MIRT698820 | STK38 | serine/threonine kinase 38 | 2 | 2 | ||||||||
MIRT701625 | MYO1B | myosin IB | 2 | 2 | ||||||||
MIRT712319 | PER2 | period circadian clock 2 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|